• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2025 年全球和区域心血管疾病过早死亡率的估计。

Estimates of global and regional premature cardiovascular mortality in 2025.

机构信息

From Division of Cardiology, Department of Medicine and Institute for Health Metrics and Evaluation (G.A.R.), and Institute for Health Metrics and Evaluation (G.N., M.H.F., A.H.M., M.N., C.J.L.M.), University of Washington, Seattle.

出版信息

Circulation. 2015 Sep 29;132(13):1270-82. doi: 10.1161/CIRCULATIONAHA.115.016021.

DOI:10.1161/CIRCULATIONAHA.115.016021
PMID:26408271
Abstract

BACKGROUND

United Nations member states have agreed to reduce premature cardiovascular disease (CVD) mortality 25% by 2025. Global CVD risk factor targets have been recommended. We produced estimates to show how selected risk factor reduction would affect CVD mortality for different regions and countries.

METHODS AND RESULTS

We used mortality, risk factor, and relative risk data from the Global Burden of Disease, Risk Factors, and Injuries (GBD) 2013 study to project CVD mortality for 188 countries up to the year 2025. We disaggregated observed CVD mortality in 1990 and 2013 into deaths attributable and unattributable to hypertension, tobacco smoking, diabetes mellitus, and obesity using an age- and sex-specific population-attributable fraction. Risk factors were projected to 2025 assuming that current trends continue. Counterfactual scenarios were then constructed reflecting CVD premature mortality if United Nations risk factor targets are achieved in the year 2025, adjusting for joint effects of risk factors. We estimate 7.8 million premature CVD deaths in 2025 if current risk factor trends continue. Premature CVD deaths would be reduced to 5.7 million if these risk factors targets are achieved as a result of a 26% reduction for men and a 23% reduction for women in the global risk of premature CVD death. Globally, decreasing the prevalence of hypertension accounted for the largest risk reduction, followed by a reduction in tobacco smoking for men and obesity for women, but these results varied by region. The impact of meeting all risk factor targets on CVD mortality varied widely by region and sex.

CONCLUSIONS

The United Nations target of a 25% reduction in premature CVD mortality by the year 2025 appears achievable for some countries, but more aggressive risk factor targets may be required if all regions are to reach this goal. Without these reductions in CVD risk factors, many countries will see no change or even an increase in premature CVD mortality.

摘要

背景

联合国会员国已同意到 2025 年将过早的心血管疾病(CVD)死亡率降低 25%。已经推荐了全球 CVD 风险因素目标。我们制作了估计值,以显示选择的风险因素减少将如何影响不同地区和国家的 CVD 死亡率。

方法和结果

我们使用来自 2013 年全球疾病、风险因素和伤害负担研究(GBD)的死亡率、风险因素和相对风险数据,对 188 个国家到 2025 年的 CVD 死亡率进行了预测。我们将 1990 年和 2013 年观察到的 CVD 死亡率分为归因于高血压、吸烟、糖尿病和肥胖的死亡和归因于这些因素的死亡,使用特定年龄和性别的人群归因分数。假设目前的趋势继续下去,那么到 2025 年,风险因素就会被预测出来。然后构建反事实情景,反映如果 2025 年联合国实现风险因素目标,CVD 过早死亡的情况,同时调整风险因素的联合效应。我们估计,如果目前的风险因素趋势继续下去,2025 年将有 780 万例过早的 CVD 死亡。如果由于男性 CVD 过早死亡率全球风险降低 26%,女性降低 23%,从而实现这些风险因素目标,过早的 CVD 死亡人数将减少到 570 万。从全球范围来看,降低高血压的患病率占风险降低的最大比例,其次是男性减少吸烟和女性减少肥胖,但这些结果因地区而异。实现所有风险因素目标对 CVD 死亡率的影响因地区和性别而异。

结论

对于一些国家来说,到 2025 年将过早的 CVD 死亡率降低 25%的联合国目标似乎是可以实现的,但如果所有地区都要实现这一目标,可能需要更积极的风险因素目标。如果不减少 CVD 风险因素,许多国家将不会看到过早的 CVD 死亡率的变化,甚至可能会增加。

相似文献

1
Estimates of global and regional premature cardiovascular mortality in 2025.2025 年全球和区域心血管疾病过早死亡率的估计。
Circulation. 2015 Sep 29;132(13):1270-82. doi: 10.1161/CIRCULATIONAHA.115.016021.
2
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.“25×25”的核心目标:实现减少全球及区域心血管疾病和中风过早死亡的目标:美国心脏协会和世界心脏联盟的一项建模研究
Circulation. 2016 Jun 7;133(23):e674-90. doi: 10.1161/CIR.0000000000000395. Epub 2016 May 9.
3
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.25×25的核心目标:实现减少全球及区域心血管疾病和中风所致过早死亡的目标:美国心脏协会和世界心脏联盟的一项建模研究
Glob Heart. 2016 Jun;11(2):251-64. doi: 10.1016/j.gheart.2016.04.002. Epub 2016 May 9.
4
Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030?到2030年,中国能否实现将非传染性疾病导致的过早死亡率降低三分之一的目标?
BMC Med. 2017 Jul 11;15(1):132. doi: 10.1186/s12916-017-0894-5.
5
Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study.六个可预防风险因素对实现 25×25 非传染性疾病死亡率降低目标的区域贡献:建模研究。
Lancet Glob Health. 2015 Dec;3(12):e746-57. doi: 10.1016/S2214-109X(15)00179-5. Epub 2015 Oct 20.
6
Risk factors for cardiovascular disease in Canada.加拿大心血管疾病的风险因素。
Can J Cardiol. 2003 Oct;19(11):1249-59.
7
Premature Mortality from Cardiovascular Disease in the Americas - Will the Goal of a Decline of "25% by 2025" be Met?美洲心血管疾病导致的过早死亡——“到2025年下降25%”的目标能否实现?
PLoS One. 2015 Oct 29;10(10):e0141685. doi: 10.1371/journal.pone.0141685. eCollection 2015.
8
Global and regional patterns in cardiovascular mortality from 1990 to 2013.1990 年至 2013 年全球和各区域心血管疾病死亡率模式。
Circulation. 2015 Oct 27;132(17):1667-78. doi: 10.1161/CIRCULATIONAHA.114.008720.
9
Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country.25 年前在一个低流行率国家评估的四项心血管危险因素的公共卫生意义。
Eur J Prev Cardiol. 2013 Feb;20(1):151-60. doi: 10.1177/1741826711430282. Epub 2011 Nov 11.
10
Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.东地中海区域心血管疾病的可避免负担:心血管相关死亡的特定风险因素的作用
High Blood Press Cardiovasc Prev. 2019 Jun;26(3):227-237. doi: 10.1007/s40292-019-00319-3. Epub 2019 Jun 21.

引用本文的文献

1
Polymorphic and Expressional Analysis of Genes and in Cardiovascular Patients Using Conventional and qPCR Approach.使用传统方法和定量聚合酶链反应方法对心血管疾病患者的基因进行多态性和表达分析。
Int J Hypertens. 2025 Aug 25;2025:7379376. doi: 10.1155/ijhy/7379376. eCollection 2025.
2
Exploring the factors that influence engagement with and experiences of integrated care for adults at risk of cardiovascular disease and mild-to-moderate mental health concerns in the UK (OptICS): a systematic review protocol.探索影响英国心血管疾病风险及轻度至中度心理健康问题成年高危人群接受综合护理并体验其效果的因素(OptICS):一项系统评价方案
Syst Rev. 2025 Aug 23;14(1):168. doi: 10.1186/s13643-025-02903-2.
3
Neutrophil extracellular traps in cardiovascular disease: a bibliometric analysis (2005-2024).
心血管疾病中的中性粒细胞胞外诱捕网:一项文献计量分析(2005 - 2024年)
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 15. doi: 10.1007/s00210-025-04507-y.
4
Foreword.前言。
Interv Cardiol. 2017 May;12(Suppl 1):4-22. doi: 10.15420/icr.2017.12.1.S1.
5
Systemic inflammation as a mediator in the link between obesity and depression: Evidence from a nationwide cohort study.全身性炎症作为肥胖与抑郁之间联系的介质:来自一项全国性队列研究的证据。
BMC Psychiatry. 2025 May 5;25(1):449. doi: 10.1186/s12888-025-06892-3.
6
Oxygen Concentration Plays a Critical Role in Fibrinogen-Mediated Platelet Activation via Inactivation of αβ and Modulation of Fibrinogen.氧浓度通过αβ的失活和纤维蛋白原的调节在纤维蛋白原介导的血小板激活中起关键作用。
Biomolecules. 2025 Mar 29;15(4):501. doi: 10.3390/biom15040501.
7
Association between estimated glucose disposal rate and future cardiovascular disease risk across glucose metabolism status: a prospective cohort study.葡萄糖代谢状态下估计的葡萄糖处置率与未来心血管疾病风险之间的关联:一项前瞻性队列研究。
Diabetol Metab Syndr. 2025 Apr 18;17(1):131. doi: 10.1186/s13098-025-01697-6.
8
The significance of small noncoding RNAs in the pathogenesis of cardiovascular diseases.小非编码RNA在心血管疾病发病机制中的意义。
Genes Dis. 2024 May 30;12(4):101342. doi: 10.1016/j.gendis.2024.101342. eCollection 2025 Jul.
9
Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled Trials.基于胰高血糖素样肽-1受体激动剂的疗法对无糖尿病肥胖个体心血管事件和心脏代谢参数的疗效:一项随机对照试验的荟萃分析
J Diabetes. 2025 Apr;17(4):e70082. doi: 10.1111/1753-0407.70082.
10
SPT: A new contributor to trans fatty acid-induced atherosclerosis.特异性IgE皮肤点刺试验:反式脂肪酸诱导动脉粥样硬化的一个新因素。
Metabol Open. 2024 Dec 25;25:100340. doi: 10.1016/j.metop.2024.100340. eCollection 2025 Mar.